TMED3 and osteosarcoma: In vitro studies revealed that TMED3 knockdown prevented the growth of osteosarcoma by reducing proliferation and migration and increasing apoptosis, whereas TMED3 knockdown prevented the formation of osteosarcoma in vivo.